1. "2013"
Formats
  1. Journal Article (2495)
  2. Meeting Abstract (1292)
  3. Book Section (250)
  4. Conference Paper (18)
  5. Book Whole (17)
  6. Review (1)
Groups
  1. Department of Medicine (1421)
  2. GSK Faculty (1000)
  3. Surgery (873)
  4. Solid Tumor Oncology Division (781)
  5. Survivorship Research (671)
  6. Sloan Kettering Institute Faculty (646)

More Groups

People
  1. Jose Baselga (74)
  2. Clifford Hudis (69)
  3. Jedd Wolchok (65)
  4. Howard Scher (62)
  5. Mithat Gonen (62)
  6. Ross Levine (62)

More People

Years
  1. 2013 (4073)
Publications
  1. Journal of Clinical Oncology (366)
  2. Blood (190)
  3. Cancer Research (119)
  4. International Journal of Radiation Oncology, Biology, Physics (88)
  5. Modern Pathology (88)
  6. Laboratory Investigation (81)

More Publications

Publishers
  1. Elsevier Inc. (502)
  2. American Society of Clinical Oncology (386)
  3. Springer (304)
  4. Nature Publishing Group (249)
  5. Elsevier Science, Inc. (206)
  6. American Society of Hematology (192)

More Publishers

Results (4073)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase II trial of radiation and cetuximab followed by irinotecan/cetuximab for children with newly diagnosed diffuse pontine tumors and high-grade astrocytomas
    Meeting Abstract

    Macy, M.; Kieran, M. W.; Chi, S. N.; Cohen, K. J.; MacDonald, T.; Smith, A. A.; Etzl, M. M.; Narendran, A.; Gore, L.; DiRenzo, J.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Impact of bilateral oophorectomy on contralateral breast cancer risk in BRCA negative women from site-specific hereditary breast cancer kindreds
    Meeting Abstract

    Long, K. C.; Pike, M. C.; Otegbeye, E.; Arnold, A. G.; Stadler, Z. K.; Robson, M. E.; Barakat, R. R.; Offit, K.; Chi, D.; Kauff, N. D.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Outcomes in patients with liver or lung metastatic castration-resistant prostate cancer (mCRPC) treated with the androgen receptor inhibitor enzalutamide: Results from the phase III AFFIRM trial
    Meeting Abstract

    Loriot, Y.; Fizazi, K.; De Bono, J. S.; Forer, D.; Hirmand, M.; Scher, H. I.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Medical oncologists' clinical experiences and comfort levels with 20 recently approved agents
    Meeting Abstract

    Love, N.; Anderson, K. C.; Flaherty, K.; Kantarjian, H. M.; Lynch, T. J.; O'Shaughnessy, J.; Sartor, A. O.; Venook, A. P.; Zelenetz, A. D.; Moss, J.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • A phase II study of mocetinostat, an oral isotype-selective histone deacetylase (HDAC) inhibitor, in combination with 5-azacitidine in patients with myelodysplastic syndrome (MDS)
    Meeting Abstract

    Luger, S. M.; O'Connell, C. L.; Klimek, V.; Cooper, M. A.; Besa, E. C.; Rossetti, J. M.; Reid, G. K.; Humphrey, R.; Martell, R. E.; Garcia-Manero, G.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Effect of renal function (RF) on outcomes in the adjuvant treatment of older women with breast cancer (> 65 years): CALGB/CTSU 49907 (CC) ancillary data study
    Meeting Abstract

    Lichtman, S. M.; Cirrincione, C.; Hurria, A.; Jatoi, A.; Theodoulou, M.; Wolff, A. C.; Gralow, J.; Morganstern, D.; Magrinat, G.; Cohen, H. J.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Long-term survival in patients with metastatic melanoma who received ipilimumab in four phase II trials
    Meeting Abstract

    Lebbé, C.; Weber, J. S.; Maio, M.; Neyns, B.; Harmankaya, K.; Hamid, O.; O'Day, S.; Chin, K. M.; McDowell, D. O.; Cykowski, L.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • A phase I dose-escalation study evaluating the effects of nivolumab (anti-PD-1; BMS-936558; ONO-4538) in patients (pts) with select relapsed or refractory hematologic malignancies
    Meeting Abstract

    Lesokhin, A. M.; Gutierrez, M.; Halwani, A. S.; Ansell, S. M.; Armand, P.; Borrello, I.; Segota, Z. E.; Cohen, A. D.; Talpaz, M.; Cattry, D.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Predicting nonsentinel lymph node metastases using established nomograms among patients with breast cancer after primary systemic therapy (PST): The transSENTINA substudy
    Meeting Abstract

    Liedtke, C.; Goerlich, D.; Van Zee, K. J.; Korndoerfer, J.; Bauerfeind, I.; Fehm, T. N.; Fleige, B.; Helms, G.; Lebeau, A.; Mai, M.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Characterization of colorectal cancer (CRC) in Lynch syndrome (LS) patients with MSH6 or PMS2 mutations
    Meeting Abstract

    Lee, J. K.; Shia, J.; Rau-Murthy, R.; Corines, M.; Salo-Mullen, E. E.; Markowitz, A.; Robson, M. E.; Offit, K.; Guillem, J. G.; Saltz, L.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save